Supplemental material
Research Article
Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone
Hee Jo Hana Department of Neurology, Yonsei University College of Medicine, Seoul, South Korea
https://orcid.org/0000-0002-9482-9244
https://orcid.org/0000-0002-9482-9244, Ha Young Shina Department of Neurology, Yonsei University College of Medicine, Seoul, South Koreahttps://orcid.org/0000-0002-4408-8265
https://orcid.org/0000-0002-4408-8265, Young-Chul Choia Department of Neurology, Yonsei University College of Medicine, Seoul, South Koreahttps://orcid.org/0000-0001-5525-6861
https://orcid.org/0000-0001-5525-6861, Seung Min Kimb Department of Neurology, Yongin Severance Hospital, Yonsei University Health System, Yongin, South Koreahttps://orcid.org/0000-0002-4384-9640
https://orcid.org/0000-0002-4384-9640 & Seung Woo Kima Department of Neurology, Yonsei University College of Medicine, Seoul, South KoreaCorrespondence[email protected]
https://orcid.org/0000-0002-5621-0811
https://orcid.org/0000-0002-5621-0811
Related Research Data
Serum uric acid level predicts the progression of amyotrophic lateral sclerosis following treatment with edaravone
Source:
Taylor & Francis
Linking provided by
